XML 22 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Series B Preferred Stock
Series C Preferred Stock
Total
Total
Cumulative Effect, Period of Adoption, Adjustment
Total
Cumulative Effect, Period of Adoption, Adjusted Balance
Total
Series B Preferred Stock
Total
Series C Preferred Stock
Preferred Stock
Preferred Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Preferred Stock
Series B Preferred Stock
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Series B Preferred Stock
Retained Earnings
Series C Preferred Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock and Other
Treasury Stock and Other
Cumulative Effect, Period of Adoption, Adjusted Balance
Non-controlling Interest
Non-controlling Interest
Cumulative Effect, Period of Adoption, Adjustment
[1]
Non-controlling Interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Balance (in shares) at Dec. 31, 2017                     4,007,000 4,007,000   87,473,708 87,473,708                            
Balance, beginning of period at Dec. 31, 2017 $ 2,680,584 $ (116) $ 2,680,468     $ 2,662,757 $ (116) $ 2,662,641     $ 265,821 $ 265,821   $ 87,474 $ 87,474 $ 791,465 $ 791,465 $ 1,577,311 $ (116) $ 1,577,195     $ (18,517) $ (18,517) $ (40,797) $ (40,797) $ 17,827   $ 17,827
Increase (Decrease) in Equity                                                          
Net income 315,628         304,358                       304,358                 11,270    
Other comprehensive income (loss), net of tax (14,621)         (14,621)                                 (14,621)            
Net investment by (distribution to) non-controlling interest (10,638)                                                   (10,638)    
Redemption of Series B Preferred Stock (in shares)                         (4,000,000)                                
Redemption of Series B Preferred Stock       $ (100,000)         $ (100,000)       $ (96,519)               $ (3,481)                
Repurchases of shares of common stock $ (212,929)         (212,929)                                     (212,929)        
Repurchases of shares of common stock (in shares) 4,668,723                                                        
Dividends on Preferred Stock       $ (1,613) $ (9,975)       $ (1,613) $ (9,975)                     $ (1,613) $ (9,975)              
Dividends on common stock $ (99,490)         (99,490)                       (99,490)                      
Common stock warrants exercised (in shares)                           553,279                              
Common stock warrants exercised                           $ 553   (553)                          
Common shares purchased by TCF employee benefit plans (in shares)                           17,594                              
Common shares purchased by TCF employee benefit plans 715         715               $ 18   697                          
Stock compensation plans, net of tax (in shares)                           153,879                              
Stock compensation plans, net of tax 8,715         8,715               $ 153   8,184                 378        
Change in shares held in trust for deferred compensation plans, at cost                               (1,166)                 1,166        
Balance (in shares) at Dec. 31, 2018                     7,000     88,198,460                              
Balance, end of period at Dec. 31, 2018 2,556,260         2,537,801         $ 169,302     $ 88,198   798,627   1,766,994         (33,138)   (252,182)   18,459    
Increase (Decrease) in Equity                                                          
Net income 306,926         295,468                       295,468                 11,458    
Other comprehensive income (loss), net of tax 87,415         87,415                                 87,415            
Reverse merger with Chemical Financial Corporation (in shares)                           65,539,678                              
Reverse merger with Chemical Financial Corporation 3,018,556         3,018,556               $ 65,540   2,687,153                 265,863        
Net investment by (distribution to) non-controlling interest (9,691)                                                   (9,691)    
Repurchases of shares of common stock $ (86,309)         (86,309)               $ (658)   (26,846)                 (58,805)        
Repurchases of shares of common stock (in shares) 2,111,725                         (657,817)                              
Dividends on Preferred Stock         (9,975)         (9,975)                       (9,975)              
Dividends on common stock $ (156,060)         (156,060)                       (156,060)                      
Stock compensation plans, net of tax (in shares)                           (114,750)                              
Stock compensation plans, net of tax 20,119         20,119               $ (114)   4,474                 15,759        
Change in shares held in trust for deferred compensation plans, at cost                               (1,328)                 1,328        
Balance (in shares) at Dec. 31, 2019                     7,000 7,000   152,965,571 152,965,571                            
Balance, end of period at Dec. 31, 2019 $ 5,727,241 $ (159,249) [1] $ 5,567,992     5,707,015 $ (159,323) [1] $ 5,547,692     $ 169,302 $ 169,302   $ 152,966 $ 152,966 3,462,080 $ 3,462,080 1,896,427 $ (159,323) [1] $ 1,737,104     54,277 $ 54,277 (28,037) $ (28,037) 20,226 $ 74 $ 20,300
Increase (Decrease) in Equity                                                          
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                                                        
Net income $ 230,041         222,759                       222,759                 7,282    
Other comprehensive income (loss), net of tax 128,396         128,396                                 128,396            
Net investment by (distribution to) non-controlling interest (9,098)                                                   (9,098)    
Repurchases of shares of common stock $ (33,098)         (33,098)               $ (873)   (32,225)                 0        
Repurchases of shares of common stock (in shares) 873,376                         873,376                              
Dividends on Preferred Stock         $ (9,975)         $ (9,975)                       $ (9,975)              
Dividends on common stock $ (214,687)         (214,687)                       (214,687)                      
Stock compensation plans, net of tax (in shares)                           473,309                              
Stock compensation plans, net of tax 29,726         29,726               $ 473   29,253                 0        
Change in shares held in trust for deferred compensation plans, at cost                               (1,306)                 1,306        
Balance (in shares) at Dec. 31, 2020                     7,000     152,565,504                              
Balance, end of period at Dec. 31, 2020 $ 5,689,297         $ 5,670,813         $ 169,302     $ 152,566   $ 3,457,802   $ 1,735,201         $ 182,673   $ (26,731)   $ 18,484    
[1] See "Note 2. Summary of Significant Accounting Policies" for further information